FDA Consumer - Generic drugs for osteoarthritis
Saturday, December 20th, 2008 The FDA has approved several generic versions of Boehringer Ingelheim’s Mobic (meloxicam) tablets. Meloxicam is indicated for the treatment of osteoarthritis.
“This is another example of our agency’s endeavor to counter rising health care costs by approving safe and effective generic alternatives to brand name drugs,” Gary Buehler, director of the FDA’s Office of Generic Drugs (OGD), said in announcing the July 2006 approval. “Meloxicam is a widely-…
